Aller au contenu principal Activer le contraste adaptéDésactiver le contraste adapté
Plus de 40 000 produits accessibles à 0€ de frais de courtage
Découvrir Boursomarkets
Fermer

NATUREX : Number of shares and voting rights as at 30 April 2014
information fournie par Actusnews 14/05/2014 à 20:00

Number of shares and voting rights
Article L.233-8-II of Commercial Law (Code de commerce) and
Article 223-16 of the General Regulation of the French Financial Markets Authority
(AMF - Autorité des Marchés Financiers)

Press release
Avignon, May 14th, 2014

30.04.2014

Total number of outstanding shares forming the capital
- 7,852,055 ordinary shares under ISIN FR0000054694
- 2,534 shares issued from stock-options under ISIN FR0000054694
7,854,589
Number of shares with double voting rights 851,442
Total number of gross voting rights 8,706,031
Number of shares without voting rights
- 6,476 bearer shares in the frame of the liquidity contract
- 6,476
Total number of exercisable voting rights* 8,699,555

* Real number of voting rights = total number of voting rights - number of shares without voting rights

If you would like to receive financial information about Naturex by e-mail, go to: www.naturex.com

  • Financial schedule
    - Q1 2014 results:
    - 2014 H1 sales
    - 2014 first-half results
    - 2014 third-quarter sales
    - 2014 third-quarter results
    - Annual revenue
    - Annual results
    26 May 2014
    25 July 2014
    29 August 2014
    4 November 2014
    28 November 2014
    3 February 2015
    31 March 2015
  • Upcoming events
    - AGM 26 June 2014

Naturex has been listed since October 1996 on NYSE Euronext in Paris, Segment B

Total number of shares comprising the share capital: 7,854,589
ISIN FR0000054694

NATUREX is a component of the CAC PEA-PME, CAC Small, Gaïa Index.
Naturex is eligible for the "long only" Deferred Settlement Service (SRD).

SYMBOL: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR Symbol: NTUXY

About Naturex

Naturex is the global leader in speciality plant-based natural ingredients. The Group is organised around three strategic markets (food & beverage, nutrition & health and personal care) and produces and markets speciality plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.

Naturex's head office is based in Avignon. The company employs more than 1,450 people with 8 sourcing offices located throughout the world and high-performance manufacturing operations across 16 sites in Europe, Morocco, the United States, Brazil, Australia and India. It also has a global commercial presence through a dedicated network of sales offices in more than 20 countries.

  • Contacts
Thierry Lambert
Chair and Chief Executive Officer
Tel.: +33 (0)4 90 23 96 89
t.lambert@naturex.com

Thierry-Bertrand Lambert
Chief Financial Officer
Tel.: +33 (0)4 90 23 96 89
t.b.lambert@naturex.com

Carole Alexandre
Investor Relations
Tel.: +33 (0)4 90 23 78 28
c.alexandre@naturex.com
Anne Catherine Bonjour
Actus Finance Press Relations
Tel.: +33 (0)1 53 67 36 93
acbonjour@actus.fr
Information réglementée
Information relative au nombre total de droits de vote et d'actions composant le capital :
- Communiqué intégral et original au format PDF :
http://www.actusnews.com/documents_communiques/ACTUS-0-35946-cp-naturex_140514.pdf

Valeurs associées

Euronext Paris 0.00%

0 commentaire

Signaler le commentaire

Fermer

Mes listes

Cette liste ne contient aucune valeur.